Background
Central and South American banana-plantation workers alleged injuries from exposure to dibromochloropropane, or DBCP, a pesticide manufactured by Dow Chemical Company and used on farms operated by a Del Monte Fresh Produce N.A. subsidiary. Plaintiff Fernando Jimenez Arias worked as a fruit-quality inspector on Bandeco banana farms in Costa Rica from 1971 to 1973. He periodically walked through fields and sometimes sheltered or slept in warehouses containing agricultural chemicals, although he never applied DBCP, saw it being applied, or identified it among the stored chemicals.
Arias alleged that DBCP exposure caused reproductive injuries, including infertility and his wife’s miscarriages. His toxicology expert, Michael J. DiBartolomeis Jr., concluded that Arias likely encountered DBCP through inhalation or skin contact and relied partly on a study associating paternal occupational DBCP exposure with increased spontaneous abortions. The circuit court excluded the expert’s opinions and granted summary judgment to Dow and Del Monte, finding no evidence that Arias had been exposed. The Intermediate Court of Appeals vacated those rulings, and the defendants sought certiorari.
The Court’s Holding
The Hawaii Supreme Court affirmed the ICA and remanded for further proceedings. It adopted the Restatement (Third) of Torts approach for causation in toxic-tort cases, organizing the inquiry as: exposure to the agent, general causation—whether the agent can cause the disease—and specific causation—whether the exposure caused the particular plaintiff’s disease. Plaintiffs must prove but-for causation by a preponderance of the evidence, generally through expert testimony, but the court rejected both the traditional substantial-factor test and the related frequency-regularity-proximity test as the governing framework for mass toxic torts.
The court declined to require precise dose quantification or another rigid exposure threshold. A plaintiff must offer evidence of exposure, including its estimated amount and duration, sufficient to support reasonable inferences rather than speculation. Arias’s extensive work on farms where Bandeco admittedly applied DBCP, his field visits, and his stays in chemical warehouses supplied enough circumstantial evidence to create a genuine factual dispute over exposure.
The court also held that the circuit court abused its discretion by excluding DiBartolomeis’s testimony. Arias’s deposition and the scientific study gave the opinion a sufficiently reliable factual foundation under Hawaii’s expert-evidence standard. Together, that testimony and the circumstantial evidence were adequate to create triable disputes over exposure and specific causation, though the plaintiffs must still prove causation at trial.
Key Takeaways
- Hawaii toxic-tort causation is analyzed through exposure, general causation, and specific causation, with but-for causation proved by a preponderance of the evidence.
- Expert testimony is generally required, but plaintiffs need not quantify an exact dose or satisfy a categorical frequency-regularity-proximity or doubling-of-risk test.
- Circumstantial exposure evidence and scientifically grounded expert opinions may defeat summary judgment even when the plaintiff did not personally observe or handle the toxic substance.
Why It Matters
The decision establishes Hawaii’s framework for proving causation in toxic-tort litigation and rejects rigid rules that could bar claims when historical exposure cannot be measured precisely. It permits flexible use of circumstantial and scientific evidence while requiring trial judges to ensure that expert opinions remain relevant, reliable, and grounded in evidence rather than speculation.
The ruling does not establish that DBCP caused Arias’s alleged injuries or impose liability on Dow or Del Monte. It holds only that the plaintiffs presented enough admissible evidence to proceed beyond summary judgment and have the disputed causation questions resolved through further proceedings.